Jacob Kokoshka
About Jacob Kokoshka
Jacob Kokoshka is a Clinical Laboratory Assistant with extensive experience in the medical field, including roles at Columbia University Irving Medical Center and Bristol Myers Squibb. He holds a Bachelor of Arts in Biology from Columbia University and has contributed to significant projects in cell therapy development.
Work at Atlantic Health System
Jacob Kokoshka has been employed at Atlantic Health System as a Clinical Laboratory Assistant since 2019. In this role, he is involved in various laboratory operations, contributing to the overall efficiency and effectiveness of clinical services. His responsibilities include performing laboratory tests, maintaining equipment, and ensuring compliance with health regulations.
Current Position at Bristol Myers Squibb
Since 2020, Jacob Kokoshka has worked as a Document Control Specialist at Bristol Myers Squibb in Summit, New Jersey. His role focuses on supporting Cell Therapy Development Operations by coordinating activities related to Good Manufacturing Practice (GMP) and Good Documentation Practice (GDP) documentation. He effectively communicates with cross-functional and regional stakeholders to ensure compliance and operational success.
Previous Experience at Columbia University Irving Medical Center
Jacob Kokoshka held two positions at Columbia University Irving Medical Center. He worked as a Medical Intern for three months in 2017 and as a Research Assistant for three months in 2018. These roles provided him with foundational experience in a clinical and research environment, enhancing his skills in biological sciences.
Education and Expertise
Jacob Kokoshka studied at Columbia University in the City of New York, where he earned a Bachelor of Arts in Biology/Biological Sciences from 2017 to 2020. Prior to that, he attended County College of Morris, achieving an Associate of Science in Biology: Pre-professional Track from 2015 to 2016. His educational background supports his expertise in laboratory practices and biological research.
Contributions to Cell Therapy Development
In his role at Bristol Myers Squibb, Jacob Kokoshka participated in a successful FDA inspection that resulted in the approval of the first CAR T-cell therapy for commercial use in patients with multiple myeloma. He also served as a Subject Matter Expert for documentation systems, managing critical documents subject to regulatory authority inspections.